121 related articles for article (PubMed ID: 31558081)
1. Knockdown of RAD54B expression reduces cell proliferation and induces apoptosis in lung cancer cells.
Xu C; Liu D; Mei H; Hu J; Luo M
J Int Med Res; 2019 Nov; 47(11):5650-5659. PubMed ID: 31558081
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells.
Wang R; Li Y; Chen Y; Wang L; Wu Q; Guo Y; Li Y; Liu J; Wang L
Oncol Rep; 2018 Sep; 40(3):1233-1242. PubMed ID: 29956808
[TBL] [Abstract][Full Text] [Related]
3. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.
Zhang Z; Li X; Han Y; Ji T; Huang X; Gao Q; Ma D
Biomed Pharmacother; 2019 Oct; 118():109341. PubMed ID: 31545289
[TBL] [Abstract][Full Text] [Related]
4. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of autophagy-related gene BECLIN1 promotes cell growth and inhibits apoptosis in the A549 human lung cancer cell line.
Wang W; Fan H; Zhou Y; Duan P; Zhao G; Wu G
Mol Med Rep; 2013 May; 7(5):1501-5. PubMed ID: 23525201
[TBL] [Abstract][Full Text] [Related]
6. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
[TBL] [Abstract][Full Text] [Related]
7. The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma.
Hwang JC; Sung WW; Tu HP; Hsieh KC; Yeh CM; Chen CJ; Tai HC; Hsu CT; Shieh GS; Chang JG; Yeh KT; Liu TC
PLoS One; 2015; 10(10):e0139435. PubMed ID: 26431531
[TBL] [Abstract][Full Text] [Related]
8. Rad54B targeting to DNA double-strand break repair sites requires complex formation with S100A11.
Murzik U; Hemmerich P; Weidtkamp-Peters S; Ulbricht T; Bussen W; Hentschel J; von Eggeling F; Melle C
Mol Biol Cell; 2008 Jul; 19(7):2926-35. PubMed ID: 18463164
[TBL] [Abstract][Full Text] [Related]
9. Aberrant hypomethylation and overexpression of the eyes absent homologue 2 suppresses tumor cell growth of human lung adenocarcinoma cells.
Gao T; Zheng S; Li Q; Ran P; Sun L; Yuan Y; Xiao C
Oncol Rep; 2015 Nov; 34(5):2333-42. PubMed ID: 26329363
[TBL] [Abstract][Full Text] [Related]
10. siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
He Z; Huang C; Lin G; Ye Y
Oncol Rep; 2016 Apr; 35(4):1933-40. PubMed ID: 26847475
[TBL] [Abstract][Full Text] [Related]
11. Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing.
McManus KJ; Barrett IJ; Nouhi Y; Hieter P
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3276-81. PubMed ID: 19218431
[TBL] [Abstract][Full Text] [Related]
12. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
13. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
[TBL] [Abstract][Full Text] [Related]
14. Actin Filament-Associated Protein 1-Like 1 Mediates Proliferation and Survival in Non-Small Cell Lung Cancer Cells.
Wang M; Han X; Sun W; Li X; Jing G; Zhang X
Med Sci Monit; 2018 Jan; 24():215-224. PubMed ID: 29323101
[TBL] [Abstract][Full Text] [Related]
15. Human INO80 chromatin-remodelling complex contributes to DNA double-strand break repair via the expression of Rad54B and XRCC3 genes.
Park EJ; Hur SK; Kwon J
Biochem J; 2010 Oct; 431(2):179-87. PubMed ID: 20687897
[TBL] [Abstract][Full Text] [Related]
16. CHAF1B promotes proliferation and reduces apoptosis in 95‑D lung cancer cells and predicts a poor prognosis in non‑small cell lung cancer.
Duan Y; Liu T; Li S; Huang M; Li X; Zhao H; Li J
Oncol Rep; 2019 Apr; 41(4):2518-2528. PubMed ID: 30720130
[TBL] [Abstract][Full Text] [Related]
17. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z
Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135
[TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
[TBL] [Abstract][Full Text] [Related]
19. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.
Romero OA; Torres-Diz M; Pros E; Savola S; Gomez A; Moran S; Saez C; Iwakawa R; Villanueva A; Montuenga LM; Kohno T; Yokota J; Sanchez-Cespedes M
Cancer Discov; 2014 Mar; 4(3):292-303. PubMed ID: 24362264
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells.
Huang H; Li T; Chen M; Liu F; Wu H; Wang J; Chen J; Li X
Cell Mol Biol Lett; 2018; 23():54. PubMed ID: 30505321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
